Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1945929Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$1.3M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#6,884
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Gary S Gilkeson as a PI. Multi-PI records show the full award amount for context.
- 5U01AI184159-03U01A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE)$1.3Maward amount
Award organization
Organizations that administered FY2026 awards listing Gary S Gilkeson as a PI.
FY2026 award administered by Medical University of South Carolina (SC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMedical University of South Carolina
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9506
- 2025$2M Cumulative Funding
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Gary S Gilkeson.